http://bio2rdf.org/drugbank_resource:DB00055_DB08813_nanopub.RAlYC0dLFL2Nm0jMvF5rYaf-wnVUu2_vfnz4DIUSMpzh0#head http://bio2rdf.org/drugbank_resource:DB00055_DB08813_nanopub.RAlYC0dLFL2Nm0jMvF5rYaf-wnVUu2_vfnz4DIUSMpzh0 http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00055_DB08813_nanopub.RAlYC0dLFL2Nm0jMvF5rYaf-wnVUu2_vfnz4DIUSMpzh0#assertion http://bio2rdf.org/drugbank_resource:DB00055_DB08813_nanopub.RAlYC0dLFL2Nm0jMvF5rYaf-wnVUu2_vfnz4DIUSMpzh0 http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00055_DB08813_nanopub.RAlYC0dLFL2Nm0jMvF5rYaf-wnVUu2_vfnz4DIUSMpzh0#provenance http://bio2rdf.org/drugbank_resource:DB00055_DB08813_nanopub.RAlYC0dLFL2Nm0jMvF5rYaf-wnVUu2_vfnz4DIUSMpzh0 http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00055_DB08813_nanopub.RAlYC0dLFL2Nm0jMvF5rYaf-wnVUu2_vfnz4DIUSMpzh0#publicationInfo http://bio2rdf.org/drugbank_resource:DB00055_DB08813_nanopub.RAlYC0dLFL2Nm0jMvF5rYaf-wnVUu2_vfnz4DIUSMpzh0 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00055_DB08813_nanopub.RAlYC0dLFL2Nm0jMvF5rYaf-wnVUu2_vfnz4DIUSMpzh0#assertion http://bio2rdf.org/drugbank:DB00055 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00055_DB08813 http://bio2rdf.org/drugbank:DB08813 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00055_DB08813 http://bio2rdf.org/drugbank_resource:DB00055_DB08813 http://purl.org/dc/terms/identifier drugbank_resource:DB00055_DB08813 http://bio2rdf.org/drugbank_resource:DB00055_DB08813 http://purl.org/dc/terms/title DDI between Drotrecogin alfa and Nadroparin - The potential benefits of drotrecogin alfa should be weighed against an increased risk of bleeding in patients receiving therapeutic doses of low molecular weight heparins such as nadroparin. Monitor for bleeding during concomitant therapy, and immediately stop infusion of drotrecogin if clinically important bleeding occurs. In patients receiving prophylactic heparin doses, consider continuing this during drotrecogin. http://bio2rdf.org/drugbank_resource:DB00055_DB08813 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00055_DB08813 http://www.w3.org/2000/01/rdf-schema#label DDI between Drotrecogin alfa and Nadroparin - The potential benefits of drotrecogin alfa should be weighed against an increased risk of bleeding in patients receiving therapeutic doses of low molecular weight heparins such as nadroparin. Monitor for bleeding during concomitant therapy, and immediately stop infusion of drotrecogin if clinically important bleeding occurs. In patients receiving prophylactic heparin doses, consider continuing this during drotrecogin. [drugbank_resource:DB00055_DB08813] http://bio2rdf.org/drugbank_resource:DB00055_DB08813_nanopub.RAlYC0dLFL2Nm0jMvF5rYaf-wnVUu2_vfnz4DIUSMpzh0#provenance http://bio2rdf.org/drugbank_resource:DB00055_DB08813_nanopub.RAlYC0dLFL2Nm0jMvF5rYaf-wnVUu2_vfnz4DIUSMpzh0#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00055_DB08813_nanopub.RAlYC0dLFL2Nm0jMvF5rYaf-wnVUu2_vfnz4DIUSMpzh0#publicationInfo http://bio2rdf.org/drugbank_resource:DB00055_DB08813_nanopub.RAlYC0dLFL2Nm0jMvF5rYaf-wnVUu2_vfnz4DIUSMpzh0#signature.MCwCFCsEJUQJWpBx http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB00055_DB08813_nanopub.RAlYC0dLFL2Nm0jMvF5rYaf-wnVUu2_vfnz4DIUSMpzh0#signature.MCwCFCsEJUQJWpBx http://purl.org/nanopub/x/hasSignature MCwCFCsEJUQJWpBx5JDzUSCWduj5H0ejAhRvcnngZh1rkPtfnTFer+SE6RB1Ow== http://bio2rdf.org/drugbank_resource:DB00055_DB08813_nanopub.RAlYC0dLFL2Nm0jMvF5rYaf-wnVUu2_vfnz4DIUSMpzh0#signature.MCwCFCsEJUQJWpBx http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00055_DB08813_nanopub.RAlYC0dLFL2Nm0jMvF5rYaf-wnVUu2_vfnz4DIUSMpzh0 http://purl.org/dc/terms/created 2018-03-30T11:12:33.331+02:00 http://bio2rdf.org/drugbank_resource:DB00055_DB08813_nanopub.RAlYC0dLFL2Nm0jMvF5rYaf-wnVUu2_vfnz4DIUSMpzh0 http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00055_DB08813_nanopub.RAlYC0dLFL2Nm0jMvF5rYaf-wnVUu2_vfnz4DIUSMpzh0 http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00055_DB08813_nanopub.RAlYC0dLFL2Nm0jMvF5rYaf-wnVUu2_vfnz4DIUSMpzh0#signature.MCwCFCsEJUQJWpBx http://bio2rdf.org/drugbank_resource:DB00055_DB08813_nanopub.RAlYC0dLFL2Nm0jMvF5rYaf-wnVUu2_vfnz4DIUSMpzh0 http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234